Vitamin D3 dose requirement to raise 25-hydroxyvitamin D to desirable levels in adolescents: Results from a randomized controlled trial
| dc.contributor.author | Al-Shaar, Laila | |
| dc.contributor.author | Mneimneh, Rania | |
| dc.contributor.author | Nabulsi, Mona M. | |
| dc.contributor.author | Maalouf, Joyce | |
| dc.contributor.author | El-Hajj Fuleihan, Ghada A. | |
| dc.contributor.department | Specialized Clinical Programs and Services | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Pediatrics and Adolescent Medicine | |
| dc.contributor.department | Scholars in Health Research Program (SHARP) | |
| dc.contributor.department | Vascular Medicine Program (VMP) | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T12:20:16Z | |
| dc.date.available | 2025-01-24T12:20:16Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Several organizations issued recommendations on desirable serum 25-hydroxy vitamin D [25(OH)D] levels and doses of vitamin D needed to achieve them. Trials allowing the formulation of evidence-based recommendations in adolescents are scarce. We investigated the ability of two doses of vitamin D3 in achieving recommended vitamin D levels in this age group. Post hoc analyses on data from a 1-year double-blind trial that randomized 336 Lebanese adolescents, aged 13 ± 2 years, to placebo, vitamin D3 at 200 IU/day (low dose), or 2000 IU/day (high dose). Serum 25(OH)D level and proportions of children achieving levels ≥20 ng/mL and 30 ng/mL were determined. At baseline, mean 25(OH)D was 15 ± 7 ng/mL, 16.4 ± 7 ng/mL in boys, and 14 ± 8 ng/mL in girls, p = 0.003, with a level ≥20 ng/mL in 18% and ≥30 ng/mL in 5% of subjects. At 1 year, mean levels were 18.6 ± 6.6 ng/mL in the low-dose group, 17.1 ± 6 ng/mL in girls, and 20.2 ± 7 ng/mL in boys, p = 0.01, and 36.3 ± 22.3 ng/mL in the high-dose group, with no sex differences. 25(OH)D increased to ≥20 ng/mL in 34% of children in the low-dose and 96% in the high-dose group, being higher in boys in the low-dose arm only; it remained ≥30 ng/mL in 4% of children in the low-dose arm but increased to 64% in the high-dose arm. Baseline 25(OH)D level, body mass index (BMI), and vitamin D dose assigned were the most significant predictors for reaching a 25(OH)D level ≥20 ng/mL and 30 ng/mL. A daily dose of 2000 IU raised 25(OH)D level ≥20 ng/mL in 96% of adolescents (98% boys versus 93% girls). Dose-response studies are needed to determine in a definitive manner the daily allowance of vitamin D for Middle Eastern adolescents with a similar profile. © 2014 American Society for Bone and Mineral Research. | |
| dc.identifier.doi | https://doi.org/10.1002/jbmr.2111 | |
| dc.identifier.eid | 2-s2.0-84897831233 | |
| dc.identifier.pmid | 24123134 | |
| dc.identifier.uri | http://hdl.handle.net/10938/34219 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Bone and Mineral Research | |
| dc.source | Scopus | |
| dc.subject | Adolescents | |
| dc.subject | Desirable levels | |
| dc.subject | Es | |
| dc.subject | Guidelines | |
| dc.subject | Iom | |
| dc.subject | Rda | |
| dc.subject | Vitamin d dose | |
| dc.subject | Adolescent | |
| dc.subject | Child | |
| dc.subject | Cholecalciferol | |
| dc.subject | Dose-response relationship, drug | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Radioimmunoassay | |
| dc.subject | Vitamin d | |
| dc.subject | 25 hydroxyvitamin d | |
| dc.subject | Alkaline phosphatase | |
| dc.subject | Calcium | |
| dc.subject | Colecalciferol | |
| dc.subject | Osteocalcin | |
| dc.subject | Phosphorus | |
| dc.subject | Placebo | |
| dc.subject | 25-hydroxyvitamin d | |
| dc.subject | Alkaline phosphatase blood level | |
| dc.subject | Article | |
| dc.subject | Body mass | |
| dc.subject | Calcium blood level | |
| dc.subject | Calcium intake | |
| dc.subject | Controlled study | |
| dc.subject | Dose response | |
| dc.subject | Double blind procedure | |
| dc.subject | Drug megadose | |
| dc.subject | Human | |
| dc.subject | Low drug dose | |
| dc.subject | Normal human | |
| dc.subject | Phosphate blood level | |
| dc.subject | Physical activity | |
| dc.subject | Post hoc analysis | |
| dc.subject | Randomized controlled trial | |
| dc.subject | Sun exposure | |
| dc.subject | Treatment response | |
| dc.subject | Vitamin blood level | |
| dc.subject | Vitamin supplementation | |
| dc.subject | Analogs and derivatives | |
| dc.subject | Blood | |
| dc.title | Vitamin D3 dose requirement to raise 25-hydroxyvitamin D to desirable levels in adolescents: Results from a randomized controlled trial | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1